European surveillance of antimicrobial resistance in Neisseria gonorrhoeae

Sexually Transmitted Infections

Volumn 86, Issue 6, 2010, Pages 427-432

  Cole, Michelle J ^a   Chisholm, Stephanie A ^a   Hoffmann, Steen ^b   Stary, Angelika ^c   Lowndes, Catherine M ^a   Ison, Catherine A ^a   Strauss, Reinhild ^d   Crucitti, Tania ^e   Sasse, André ^f   Hadjianastassiou, Chrystalla ^g   Cowan, Susan ^b   Uusküla, Anneli ^h   Voiko, Rutta ⁱ   Hiltunen Back, Eija ^j   Goulet, Véronique ^k   Sednaoui, Patrice ^l   De Barbevrac, Bertille ^m   Kohl, Peter ⁿ   Hamouda, Osamah ^o   Konte, Vasileia ^p   Tzelepi, Eva ^q   Sigmundsdóttir, Guorún ^r   Hauksdottir, Guorun ^s   O'Hora, Aidan ^t   Barry, Helen ^u   Stefanelli, Paola ^v   Suligoi, Barbara ^v   Pirsko, Judite ^w   Lavrinovica, Elvira ^w   Barbara, Christopher ^x   Melillo, Jackie Maistre ^y   Linde, Ineke ^z   Van Der Sande, Marianne ^d   Klovstad, Hilde ^aa   Skogen, Vegard ^d   Azevedo, Jacinta ^ab   Borrego, Maria José ^ac   Mikas, Jan ^ad   Klavs, Irena ^ae   Andlovic, Alenka ^af   Vazquez, Julio ^ag   Diez, Mercedes ^ag   Blaxhult, Anders ^ah   Velicko, Inga ^ah   Fredlund, Hans ^ai   Unemo, Magnus ^ai   Altan, Peyman ^aj   Wallace, Lesley ^ak   Young, Hugh ^al   Catchpole, Mike ^a   Hughes, Gwenda ^a   Savage, Emma ^a   more..

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b STATENS SERUM INSTITUT   (Denmark)

^c Ambulatorium fur Pilzinfektionen   (Austria)

^d FM for Health Family and Youth ^*  (Norway)

^e INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^f SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^g Ministry of Health   (Cyprus)

^h TARTU UNIVERSITY CLINICS   (Estonia)

ⁱ WEST TALLINN CENTRAL HOSPITAL   (Estonia)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k INSTITUT DE VEILLE SANITAIRE   (France)

^l INSTITUT ALFRED FOURNIER   (France)

^m National Reference Centre of Chlamydia Infection   (France)

ⁿ VIVANTES KLINIKUM NEUKÖLLN   (Germany)

^o ROBERT KOCH INSTITUTE   (Germany)

^p Hellenic Centre for Infectious Disease Control   (Greece)

^q HELLENIC PASTEUR INSTITUTE   (Greece)

^r Centre for Infectious Disease Control   (Iceland)

^s LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^t HEALTH PROTECTION SURVEILLANCE CENTRE   (Ireland)

^u ST JAMES S HOSPITAL   (Ireland)

^v ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^w State Centre of Sexually Transmitted and Skin Diseases   (Latvia)

^x ST LUKE S HOSPITAL   (Malta)

^y Infectious Disease Prevention and Control Unit   (Malta)

^z MUNICIPAL HEALTH SERVICE   (Netherlands)

^aa NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^ab General Directorate of Health (DGS)   (Portugal)

^ac NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

^ad National Public Health Agency of the Slovak Republic   (Slovakia)

^ae NATIONAL INSTITUTE OF PUBLIC HEALTH   (Slovenia)

^af UNIVERSITY OF LJUBLJANA   (Slovenia)

^ag INSTITUTO DE SALUD CARLOS III   (Spain)

^ah SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^ai ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^aj MINISTRY OF HEALTH   (Turkey)

^ak HEALTH PROTECTION SCOTLAND   (United Kingdom)

^al Scottish Bacterial Sexually Transmitted Infections Reference Laboratory   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG MONITORING; EUROPE; GONORRHEA; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EUROPE; FEMALE; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NEISSERIA GONORRHOEAE; QUALITY ASSURANCE, HEALTH CARE; SENTINEL SURVEILLANCE; YOUNG ADULT;

EID: 78449240179     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sti.2010.044164     Document Type: Article

References (30)

1. World Health Organisation. Sexually transmitted diseases: gonorrhoea. http://www.who.int/vaccine-research/diseases/soa-std/en/index2.html (accessed 9 Jul 2010).
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999;75:3-17.
3. WHO Western Pacific Gonococccal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2006. Commun Dis Intell 2008;32:48-51.
4. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2007 Supplement, Gonococcal Isolate Surveillance Project (GISP) Annual Report 2007, 2009. http://www.cdc.gov/std/GISP2007/ (accessed 9 Jul 2010).
5. Dillon JA, Ruben M, Li H, et al. Challenges in the control of gonorrhea in South America and the Caribbean: monitoring the development of resistance to antibiotics. Sex Transm Dis 2006;33:87-95.
6. Health Protection Agency. GRASP 2008 report: trends in antimicrobial resistant Gonorrhoea, 2009. http://www.hpa.org.uk/web/HPAwebFile/HPAweb-C/ 1245914960426 (accessed 9 Jul 2010).
7. Kubanova A, Frigo N, Kubanov A, et al. National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobial drugs for gonorrhoea treatment in Russia. Sex Transm Infect 2008;84:285-9.
8. Tapsall J. Annual report of the Australian Gonococcal Surveillance Programme, 2008. Commun Dis Intell 2009;33:268-74.
9. European Surveillance of Sexually Transmitted Infections (ESSTI). Sexually Transmitted Infections in Europe. Annual Report 3. Health Protection Agency 2008. http://www.essti.org/docs/ESSTI-Surveillance-Annual-Report-2008.pdf (accessed 9 July 2010).
10. Martin IM, Hoffmann S, Ison CA. European Surveillance of Sexually Transmitted Infections (ESSTI): the first combined antimicrobial susceptibility data for Neisseria gonorrhoeae in Western Europe. J Antimicrob Chemother 2006;58:587-93.
11. Tapsall J. Antimicrobial resistance in Neisseria gonorrhoeae. Geneva: World Health Organisation, 2001. WHO document WHO/CDS/CSR/DRS/2001.3. http://whqlibdoc.who.int/hq/2001/WHO-CDS-CSR-DRS-2001.3.pdf (accessed 9 Jul 2010).
12. Bignell C. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea in adults. Int J STD AIDS 2009;20:453-7.
13. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Seventeenth Informational Supplement. CLSI document M100-S17. Wayne, USA: Clinical and Laboratory Standards Institute, 2007.
14. European Committee on Antimicrobial Susceptibility Testing - EUCAST. Breakpoint tables for interpretation of MICs and zone diameters. Version 1.1, p40, 2010. http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/Disk- test-documents/EUCAST-breakpoints-v1.1.pdf (accessed 9 Jul 2010).
15. Enders M, Turnwald-Maschler A, Regnath T. Antimicrobial resistance of Neisseria gonorrhoeae isolates from the Stuttgart and Heidelberg areas of southern Germany. Eur J Clin Microbiol Infect Dis 2006;25:318-22. (Pubitemid 43829335)
16. Martin G, Cowan S, Hoffmann S. Gonorrhoea 2009. Henrik Andersen P, ed. In: EPI-NEWS. Copenhagen: Statens Serum Institut 2009,22. http://www.ssi.dk/ graphics/en/news/epinews/2009/pdf/epinews-22.pdf (accessed 9 Jul 2010).
17. Farhi D, Hotz C, Poupet H, et al. Neisseria gonorrhoeae antibiotic resistance in Paris, 2005 to 2007: implications for treatment guidelines. Acta Derm Venereol 2009;89:484-7.
18. Koedijk F, van Veen MG, de Neeling AJ, et al. Increasing trend in gonococcal resistance to ciprofloxacin in the Netherlands, 2006-2008. Sex Transm Infect 2009;86:41-5.
19. Palmer HM, Dave J. Gonococcal antibiotic surveillance in Scotland (GASS): prevalence, patterns and trends in 2008. HPS Weekly Report 43[2009/20], 2009. http://www.documents.hps.scot.nhs.uk/ewr/pdf2009/0920.pdf (accessed 9 July 2010).
20. Tzelepi E, Avgerinou H, Flemetakis A, et al. Changing figures of antimicrobial susceptibility and serovar distribution in Neisseria gonorrhoeae isolated in Greece. Sex Transm Dis 2010;37:115-20.
21. Velicko I, Unemo M. Increase in reported gonorrhoea cases in Sweden, 2001-2008. Euro Surveill 2009;14:383-7.
22. Tapsall J, Read P, Carmody C, et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. J Med Microbiol 2009;58:683-7.
23. Wang SA, Lee MV, O'Connor N, et al. Multidrug-resistant Neisseria gonorrhoeae with decreased susceptibility to cefixime-Hawaii, 2001. Clin Infect Dis 2003;37:849-52.
24. Yokoi S, Deguchi T, Ozawa T, et al. Threat to cefixime treatment for gonorrhea. Emerg Infect Dis 2007;13:1275-7.
25. Furuya R, Nakayama H, Kanayama A, et al. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother 2006;12:172-6.
26. Sathia L, Ellis B, Phillip S, et al. Pharyngeal gonorrhoea - is dual therapy the way forward? Int J STD AIDS 2007;18:647-8.
27. Palmer HM, Young H, Winter A, et al. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland. J Antimicrob Chemother 2008;62:490-4.
28. Chisholm SA, Neal TJ, Alawattegama AB, et al. Emergence of high-level azithromycin resistance in Neisseria gonorrhoeae in England and Wales. J Antimicrob Chemother 2009;64:353-8.
29. Starnino S, Stefanelli P. Azithromycin-resistant Neisseria gonorrhoeae strains recently isolated in Italy. J Antimicrob Chemother 2009;63:1200-4.
30. Galarza PG, Alcala B, Salcedo C, et al. Emergence of high level azithromycin-resistant Neisseria gonorrhoeae strain isolated in Argentina. Sex Transm Dis 2009;36:787-8.